Oncolytics Biotech Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.1% | -10.1% | -44.1% | +5.1% | +409.1% | -31.5% | +8.4% | -16.5% | -0.8% | -70.9% | -19.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -37.8% | +13.6% | -3.9% | +0.3% | +14.9% | +19.7% | -0.2% | -12.0% | +17.4% | +15.7% | -13.8% | |
| – | +2.7% | +4.4% | +15.9% | +16.6% | +31.9% | +30.9% | +2.8% | -36.4% | +44.5% | -14.6% | +52.6% | |
| – | -14.9% | -4.5% | +2.0% | +6.8% | +20.9% | +26.4% | +3.0% | -24.4% | +28.4% | +0.3% | +12.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +281.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -53.5% | +197.3% | +1,409.5% | +287.3% | +2,168.0% | -123.8% | – | +26.3% | +18.1% | +29.9% | -16.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.